retatrutide what is it clinical trials First phase 3 data for are here folks. This drug a barn burner. This was only 68 weeks and was geared towards osteoarthritis of the knee. Massive pain improvements and Retatrutide Results: 28.3% Weight Loss
Description
Data from cardiovascular outcomes trials and real-world studies demonstrate consistent benefits of combination therapy across diverse subpopulations, including those with established atherosclerotic cardiovascular disease or chronic kidney disease

Evidence shows some regain after stopping GLP-1s
GLP-1 medications are a breakthrough for weight loss and metabolic healthbut commonly cause digestive side effects that can hinder adherence

Ava Peterson, 31, Nurse (US)
Patients living in major cities such as